A dose-response study in mice of a tetravalent recombinant dengue envelope domain III protein secreted from insect cells

Infect Genet Evol. 2020 Nov:85:104427. doi: 10.1016/j.meegid.2020.104427. Epub 2020 Jun 18.

Abstract

Background: DENV is the most globally prevalent mosquito-transmitted virus. Induction of a broadly and potently immune response is desirable for dengue vaccine development.

Methods: Several formulations of secreted tetravalent EDIII protein containing different amounts of antigen from eukaryotic cells were used to evaluate the immune responses in mice.

Results: We demonstrated that the tetravalent protein induced humoral immunity against all four serotypes of DENV, even at the lowest dose assayed. Besides, cellular immunities against DENV-1 and DENV-2 were elicited by medium dose group. Importantly, the immune responses induced by the tetravalent protein were functional in clearing DENV-2 in circulation of mice.

Conclusions: We believe that the tetravalent secreted EDIII protein is a potential vaccine candidate against DENV and suggest further detailed studies of this formulation in nonhuman primates.

Keywords: Cellular immunity; Dengue virus; Humoral immunity; Tetravalent; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / immunology*
  • Antigens, Viral / genetics
  • Antigens, Viral / immunology*
  • Cell Line
  • Chlorocebus aethiops
  • Dengue / immunology
  • Dengue Vaccines / immunology
  • Dengue Virus / immunology*
  • Female
  • Humans
  • Immunity, Cellular
  • Immunity, Humoral
  • K562 Cells
  • Mice
  • Mice, Inbred BALB C
  • Protein Domains
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology*
  • Vero Cells
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology*

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Dengue Vaccines
  • Recombinant Proteins
  • Viral Envelope Proteins